Menstrual blood derived mesenchymal cells ameliorate cardiac fibrosis via inhibition of endothelial to mesenchymal transition in myocardial infarction

Int J Cardiol. 2013 Sep 30;168(2):1711-4. doi: 10.1016/j.ijcard.2013.03.126. Epub 2013 Apr 20.

Authors

Zhaocai Zhang¹, Jian-An Wang, Yinchuan Xu, Zhi Jiang, Rongrong Wu, Lihan Wang, Panpan Chen, Xinyang Hu, Hong Yu

Affiliation

¹ Department of Cardiology, Second Affiliated Hospital, Zhejiang University College of Medicine, PR China; Cardiovascular Key Lab of Zhejiang Province, Hangzhou, 310009, PR China.

PMID: 23608402
DOI: 10.1016/j.ijcard.2013.03.126

No abstract available

Keywords: Cardiac fibroblast; Endothelial to mesenchymal transition; Menstrual blood; Mesenchymal stem cell; Myocardial infarction.

Publication types

Letter

MeSH terms

Animals
Cell Differentiation / physiology*
Cells, Cultured
Endothelium, Vascular / cytology
Endothelium, Vascular / physiology*
Female
Fibrosis
Humans
Male
Menstruation / blood*
Mesenchymal Stem Cell Transplantation / methods*
Mesenchymal Stem Cells / physiology*
Myocardial Infarction / pathology
Myocardial Infarction / surgery*
Rats
Rats, Sprague-Dawley